This study conducted in Africa found that personalized treatment on the basis of renin/aldosterone phenotyping massively improved blood pressure control in African hypertensive patients who were not responding well to standard treatment. This approach shows promise for improving blood pressure management in Africans and African Americans with resistant hypertension. Here, REN is linked to hypertensive disorder.